Plasma glucagon-like peptide 1 and peptide YY levels are not altered in symptomatic fructose-sorbitol malabsorption

Author： Valeur Jørgen   Øines Eliann   Helvik Morken Mette   Juul Holst Jens   Berstad Arnold  

Publisher： Informa Healthcare

ISSN： 0036-5521

Source： Scandinavian Journal of Gastroenterology, Vol.43, Iss.10, 2008-01, pp. : 1212-1218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glucagon-like Peptide 2

By Drucker D.J.  

Trends in Endocrinology and Metabolism, Vol. 10, Iss. 4, 1999-05 ,pp. : 153-156

Elsevier

Access to resources Recommend Favorite

Glucagon-Like Peptide 1 and the Cardiovascular System

By  

Current Diabetes Reviews, Vol. 10, Iss. 5, 2014-09 ,pp. : 302-310

Bentham Science Publishers

Access to resources Recommend Favorite

Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1

By Nagell C. F.   Wettergren A.   Pedersen J. F.   Mortensen D.   Holst J. J.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 4, 2004-04 ,pp. : 353-358

Informa Healthcare

Access to resources Recommend Favorite

Harnessing the Therapeutic Potential of Glucagon-Like Peptide-1: A Critical Review

By Baggio L.L.   Drucker D.J.  

Treatments in Endocrinology, Vol. 1, Iss. 2, 2002-02 ,pp. : 117-125

Adis International

Access to resources Recommend Favorite

Glucagon-like peptide-1 prevents beta cell glucolipotoxicity

By Buteau J.   El-Assaad W.   Rhodes C.   Rosenberg L.   Joly E.   Prentki M.  

Diabetologia, Vol. 47, Iss. 5, 2004-05 ,pp. : 806-815

Springer Publishing Company

Access to resources Recommend Favorite